AI-generated summary
The authors report a single 35-year-old woman with biopsy-confirmed erythema dyschromicum perstans treated with 1,550 nm fractional laser sessions plus topical tacrolimus over 5 months. Her condition improved by more than 75%, and the result was maintained at 8 months. The authors describe the combination as potentially safe and effective but call for prospective comparative studies.
- Who or what was studied
- One 35-year-old female patient with biopsy-confirmed erythema dyschromicum perstans
- Limits stated in the abstract
- The report describes a single patient case, so no comparison group or generalizable conclusions are possible.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 550 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.